Sensus Healthcare to Host First Quarter 2019 Financial Results and Business Update Conference Call on May 9, 2019
BOCA RATON, Fla., April 25, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 9, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter […]
Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World’s First Sculptura™ Intraoperative Radiation Therapy System
Sculptura™ Provides Single Treatment During Surgery for Cancer Patients BOCA RATON, Fla., April 24, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, today announced that the Company has signed a research and development agreement with the Perelman School of Medicine at the University of […]
Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare’s Superficial Radio Therapy
Sensus’ SRT-100™ Indicates High Cure Rates in Long-Term Retrospective Study BOCA RATON, Fla., April 23, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in non-invasive treatments for both oncological and non-oncological conditions, announced today topline results from a five-year retrospective study of non-melanoma skin cancer (NMSC) patients treated with Superficial Radio […]
Sensus Healthcare Mentioned in SFBJ’s Business of Medicine: ‘It’s an exciting time for the life sciences in Florida’
One of the reasons why Florida is one of the leaders in clinical trial providers is because of the population of this state. The disease population, the elderly, but also healthy volunteers. Florida is No. 2 in the nation for clinical trial providers. Another area of expertise in the South Florida region is RNA technology […]
